Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pacemaker technique could rival standard for heart failure

NCT ID NCT06241651

Recruiting now Disease control Sponsor: The First Affiliated Hospital with Nanjing Medical University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a newer pacing method called conduction system pacing (CSP) with the standard biventricular pacing (BiVP) in heart failure patients who already have a right ventricular pacemaker and need an upgrade. Researchers want to see if CSP is as good as BiVP at improving heart function over six months. The trial will enroll 66 adults with heart failure and a history of right ventricular pacing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Conduction system pacing (a type of heart pacemaker) and biventricular pacing (standard pacemaker)
What this could lead to
If successful, this could show that a newer pacing method works as well as the standard one, offering patients another option for managing heart failure.
What could go wrong
This is a small, early-stage study with only 66 participants, so results may not apply to everyone. The newer pacing method may not be as effective or could have unexpected risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIVENTRICULAR PACING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIVENTRICULAR PACING CARDIAC RESYNCHRONIZATION THERAPY CONDUCTION SYSTEM PACING HEART FAILURE RIGHT VENTRICULAR PACING

Contacts and locations

Locations

  • The First Affiliated Hospital with Nanjing Medical University

    RECRUITING

    Nanjing, Jiangsu, 210029, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.